Uzm. Dr. Ufuk Çamanlı
Is this your profile? Claim it and verify your details.
Claim profileTrust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologysaglik.gov.trFrom source
- Institutionİzmir Şehir Hastanesisaglik.gov.trFrom source
- Publications4 publicationsOpenAlex, ORCID, Europe PMCFrom source
- ORCID0000-0003-4494-9309ORCIDFrom source
- Last synchronised5 November 2026 09:07https://izmirsehir.saglik.gov.tr/TR-1046789/doktorlarimiz.html#ufuk-camanlisaglik.gov.tr
Scientific work
Publications
-
Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
International Journal of Cancer, 2025
DOI 10.1002/ijc.70213 PMID 41147655 3 citations (Europe PMC) Source: OpenAlex
-
Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)
Turkish Journal of Gastroenterology, 2025
DOI 10.5152/tjg.2025.24784 PMID 40241388 1 citation (Europe PMC) Open-access full textSource: ORCID
-
Impact of Treatment Duration in First-Line Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Multicenter Real-World Retrospective Study
Medicina, 2025
DOI 10.3390/medicina61071230 PMID 40731859 Open-access full textSource: OpenAlex
-
Prevalence of Insomnia and Associated Factors in Female Patients Undergoing Chemotherapy
Nature and science of sleep, 2025
DOI 10.2147/nss.s554960 PMID 41084526 1 citation (Europe PMC) Open-access full textSource: Europe PMC